Buron Nutrascience Corp (BRCNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,538 | -996 | -3,640 | -2,674 | -1,820 |
| Depreciation Amortization | 15 | 11 | 76 | 60 | 45 |
| Accounts receivable | -206 | -172 | 21 | 87 | 17 |
| Other Working Capital | 64 | 35 | -145 | -184 | -281 |
| Other Operating Activity | 355 | 259 | 528 | 324 | 300 |
| Operating Cash Flow | $-1,310 | $-863 | $-3,160 | $-2,386 | $-1,738 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -374 | N/A | N/A | N/A | N/A |
| PPE Investments | -3 | 0 | -14 | -10 | -10 |
| Purchase Of Investment | -6,061 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-6,438 | $0 | $-14 | $-10 | $-10 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 189 | 187 | 953 | N/A | N/A |
| Debt Issued | N/A | -2,991 | N/A | 379 | N/A |
| Debt Repayment | -1,901 | -1,876 | N/A | N/A | N/A |
| Common Stock Issued | 11,742 | 11,584 | N/A | N/A | N/A |
| Other Financing Activity | -1,291 | -1,185 | -14 | -14 | -14 |
| Financing Cash Flow | $8,740 | $5,719 | $939 | $365 | $-14 |
| Exchange Rate Effect | 0 | 0 | 2 | 9 | 1 |
| Beginning Cash Position | 371 | 366 | 2,607 | 2,589 | 2,618 |
| End Cash Position | 1,362 | 5,221 | 373 | 567 | 857 |
| Net Cash Flow | $991 | $4,855 | $-2,234 | $-2,023 | $-1,762 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,310 | -863 | -3,160 | -2,386 | -1,738 |
| Capital Expenditure | -3 | 0 | -14 | -10 | -10 |
| Free Cash Flow | -1,313 | -863 | -3,174 | -2,396 | -1,748 |